IL83819A - Acetic acid ester of haloperidol and pharmaceutical compositions thereof - Google Patents
Acetic acid ester of haloperidol and pharmaceutical compositions thereofInfo
- Publication number
- IL83819A IL83819A IL83819A IL8381987A IL83819A IL 83819 A IL83819 A IL 83819A IL 83819 A IL83819 A IL 83819A IL 8381987 A IL8381987 A IL 8381987A IL 83819 A IL83819 A IL 83819A
- Authority
- IL
- Israel
- Prior art keywords
- haloperidol
- pharmaceutical compositions
- acetic acid
- acid ester
- compounds
- Prior art date
Links
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 229960003878 haloperidol Drugs 0.000 title abstract 3
- 150000002168 ethanoic acid esters Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- XAMUDJHXFNRLCY-UHFFFAOYSA-N phenthoate Chemical compound CCOC(=O)C(SP(=S)(OC)OC)C1=CC=CC=C1 XAMUDJHXFNRLCY-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868621892A GB8621892D0 (en) | 1986-09-11 | 1986-09-11 | Organic compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL83819A0 IL83819A0 (en) | 1988-02-29 |
| IL83819A true IL83819A (en) | 1992-02-16 |
Family
ID=10604021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83819A IL83819A (en) | 1986-09-11 | 1987-09-08 | Acetic acid ester of haloperidol and pharmaceutical compositions thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4855307A (de) |
| EP (1) | EP0260070B1 (de) |
| JP (1) | JPS6377857A (de) |
| AT (1) | ATE92917T1 (de) |
| AU (1) | AU591334B2 (de) |
| DE (1) | DE3786966T2 (de) |
| DK (1) | DK166320C (de) |
| ES (1) | ES2058120T3 (de) |
| FI (1) | FI88155C (de) |
| GB (1) | GB8621892D0 (de) |
| IE (1) | IE60902B1 (de) |
| IL (1) | IL83819A (de) |
| NO (1) | NO169893C (de) |
| NZ (1) | NZ221711A (de) |
| PT (1) | PT85678B (de) |
| ZA (1) | ZA876819B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3742580C1 (de) * | 1987-12-16 | 1989-05-11 | Schaper & Bruemmer Gmbh | Verwendung des alpha,alpha-Diphenyl-alpha-(3-carboxy-propionyloxy)-essigsaeure-4-(N-methylpiperidyl)-esters zur Behandlung hypertoner Funktionszustaende im Bereich der Harnblase |
| US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
| DK238190D0 (da) * | 1990-10-03 | 1990-10-03 | Lundbeck & Co As H | Depotderivater |
| EP1263729B1 (de) | 2000-03-06 | 2006-12-20 | Acadia Pharmaceuticals Inc. | Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten |
| EP1787984B1 (de) * | 2000-03-06 | 2016-10-19 | Acadia Pharmaceuticals Inc. | Azacyclische verbindungen zur verwendung bei der behandlung von erkrankungen im zusammenhang mit serotonin |
| KR100974901B1 (ko) | 2001-12-28 | 2010-08-10 | 아카디아 파마슈티칼스 인코포레이티드 | 모노아민 수용체 조정자로서의 스피로아자사이클릭 화합물 |
| US7538222B2 (en) | 2002-06-24 | 2009-05-26 | Acadia Pharmaceuticals, Inc. | N-substituted piperidine derivatives as serotonin receptor agents |
| KR20050008846A (ko) | 2002-06-24 | 2005-01-21 | 아카디아 파마슈티칼스 인코포레이티드 | 세로토닌 수용체 제제로서의 ｎ-치환된 피페리딘 유도체 |
| US7253186B2 (en) | 2002-06-24 | 2007-08-07 | Carl-Magnus Andersson | N-substituted piperidine derivatives as serotonin receptor agents |
| CA2512639C (en) | 2003-01-16 | 2012-10-30 | Acadia Pharmaceuticals Inc. | Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases |
| US7820695B2 (en) | 2004-05-21 | 2010-10-26 | Acadia Pharmaceuticals, Inc. | Selective serotonin receptor inverse agonists as therapeutics for disease |
| US20050261278A1 (en) | 2004-05-21 | 2005-11-24 | Weiner David M | Selective serotonin receptor inverse agonists as therapeutics for disease |
| KR101260036B1 (ko) | 2004-09-27 | 2013-05-06 | 아카디아 파마슈티칼스 인코포레이티드 | Ｎ－(４－플루오로벤질)－ｎ－(１－메틸피페리딘－４－일)－ｎ＇－(４－(２－메틸프로필옥시)페닐메틸)카르바미드와그의 타르트레이트염 및 결정형의 합성 |
| US7790899B2 (en) | 2004-09-27 | 2010-09-07 | Acadia Pharmaceuticals, Inc. | Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms |
| ES2423485T3 (es) | 2007-03-19 | 2013-09-20 | Acadia Pharmaceuticals Inc. | Asociaciones de agonistas y antagonistas inversos 5-HT2A con antipsicóticos |
| EP3325444B1 (de) | 2015-07-20 | 2021-07-07 | Acadia Pharmaceuticals Inc. | Verfahren zur herstellung von n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy) phenylmethyl)carbamide und seinem tartrat-salt und seiner polymorphen form c |
| WO2017165635A1 (en) | 2016-03-25 | 2017-09-28 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome p450 modulators |
| US10953000B2 (en) | 2016-03-25 | 2021-03-23 | Acadia Pharmaceuticals Inc. | Combination of pimavanserin and cytochrome P450 modulators |
| EP3558311A1 (de) | 2016-12-20 | 2019-10-30 | Acadia Pharmaceuticals Inc. | Pimavanserin allein oder in kombination zur verwendung in der behandlung von morbus-alzheimer-psychose |
| US11135211B2 (en) | 2017-04-28 | 2021-10-05 | Acadia Pharmaceuticals Inc. | Pimavanserin for treating impulse control disorder |
| WO2019046167A1 (en) | 2017-08-30 | 2019-03-07 | Acadia Pharmaceuticals Inc. | PIMAVANSERIN FORMULATIONS |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB895309A (en) * | 1959-11-18 | 1962-05-02 | Res Lab Dr C Janssen Nv | Pyrrolidine and piperidine derivatives |
| US3408356A (en) * | 1965-08-31 | 1968-10-29 | Squibb & Sons Inc | Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like |
| DE1695194A1 (de) * | 1966-07-11 | 1971-03-18 | Hoffmann La Roche | Verfahren zur Herstellung von Piperidinderivaten |
| US4070473A (en) * | 1973-01-26 | 1978-01-24 | Ab Ferrosan | Piperidino-butyrophenones |
| JPS568318A (en) * | 1979-06-28 | 1981-01-28 | Janssen Pharmaceutica Nv | Non oral long acting composition of haloperidol and bromperidol derivative |
-
1986
- 1986-09-11 GB GB868621892A patent/GB8621892D0/en active Pending
-
1987
- 1987-09-03 ES ES87307799T patent/ES2058120T3/es not_active Expired - Lifetime
- 1987-09-03 AT AT87307799T patent/ATE92917T1/de not_active IP Right Cessation
- 1987-09-03 DE DE87307799T patent/DE3786966T2/de not_active Expired - Lifetime
- 1987-09-03 IE IE236687A patent/IE60902B1/en not_active IP Right Cessation
- 1987-09-03 EP EP87307799A patent/EP0260070B1/de not_active Expired - Lifetime
- 1987-09-04 US US07/093,404 patent/US4855307A/en not_active Expired - Lifetime
- 1987-09-08 NZ NZ221711A patent/NZ221711A/xx unknown
- 1987-09-08 IL IL83819A patent/IL83819A/xx not_active IP Right Cessation
- 1987-09-10 AU AU78232/87A patent/AU591334B2/en not_active Ceased
- 1987-09-10 NO NO873785A patent/NO169893C/no unknown
- 1987-09-10 PT PT85678A patent/PT85678B/pt not_active IP Right Cessation
- 1987-09-10 FI FI873924A patent/FI88155C/fi not_active IP Right Cessation
- 1987-09-11 ZA ZA876819A patent/ZA876819B/xx unknown
- 1987-09-11 JP JP62226744A patent/JPS6377857A/ja active Pending
- 1987-09-11 DK DK479587A patent/DK166320C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IE60902B1 (en) | 1994-08-24 |
| AU7823287A (en) | 1988-03-17 |
| NO169893B (no) | 1992-05-11 |
| EP0260070B1 (de) | 1993-08-11 |
| NO873785D0 (no) | 1987-09-10 |
| NO169893C (no) | 1992-08-19 |
| PT85678B (pt) | 1990-05-31 |
| EP0260070A1 (de) | 1988-03-16 |
| DK166320B (da) | 1993-04-05 |
| GB8621892D0 (en) | 1986-10-15 |
| PT85678A (en) | 1987-10-01 |
| ATE92917T1 (de) | 1993-08-15 |
| ZA876819B (en) | 1988-06-29 |
| AU591334B2 (en) | 1989-11-30 |
| ES2058120T3 (es) | 1994-11-01 |
| US4855307A (en) | 1989-08-08 |
| FI88155C (fi) | 1993-04-13 |
| DE3786966T2 (de) | 1994-03-17 |
| DK166320C (da) | 1993-08-23 |
| DK479587A (da) | 1988-03-12 |
| NO873785L (no) | 1988-03-14 |
| DE3786966D1 (de) | 1993-09-16 |
| FI873924A0 (fi) | 1987-09-10 |
| IE872366L (en) | 1988-03-11 |
| DK479587D0 (da) | 1987-09-11 |
| NZ221711A (en) | 1989-11-28 |
| FI88155B (fi) | 1992-12-31 |
| IL83819A0 (en) | 1988-02-29 |
| JPS6377857A (ja) | 1988-04-08 |
| FI873924L (fi) | 1988-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL83819A0 (en) | Acetic acid ester of haloperidol and pharmaceutical compositions thereof | |
| DE2963183D1 (en) | 1,4-dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions | |
| ES2074846T3 (es) | Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen. | |
| FI945703A0 (fi) | 3,4,4-trisybstituoitujen piperidinyyli-N-alkyylikarboksylaattien ja välituotteiden valmistus | |
| DK34289D0 (da) | Madlavnings/salatolie | |
| ATE2271T1 (de) | 4-(substituierte thiazolyl)-3-hydroxy-3-pyrrolin2,5-dion-verbindungen, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzung. | |
| DE3572807D1 (en) | A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use | |
| IL67623A (en) | 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it | |
| ATE22804T1 (de) | Pharmazeutische zusammensetzung. | |
| FI881609A0 (fi) | Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel. | |
| DE3873232D1 (de) | Ein dideoxynukleosid enthaltendes arzneimittel. | |
| NO891260D0 (no) | Fremgangsmaate for fremstilling av 4-aryl-4-piperidin (eller pyrrolidin eller hexahydroazepin) carbinoler. | |
| EP0191724A3 (de) | 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| DK149888C (da) | Analogifremgangsmaade til fremstilling af 1-(1,3,4-oxadiazolyl-2-phenoxy)-3-(4-phenylpiperazinyl)-propan-2-oler eller fysiologisk acceptable syreadditionssalte heraf | |
| KR960014779B1 (en) | Hair treatment composition | |
| DE69715733D1 (de) | Verfahren zur Herstellung von 5-Brom-2-Fluorbenzolboronsäure | |
| IE792328L (en) | Derivatives of dihydropyrrole and tetrahydropyridine. | |
| DE3762854D1 (de) | Pharmazeutische zusammensetzungen mit inhalt von 5-phenyl-1,3-dioxoalkenylverbindungen. | |
| FI875538A7 (fi) | Uudet maleimideihin perustuvat yhdisteet ja uudet, niitä sisältävät valolla kovettuvat koostumukset. | |
| DE59006944D1 (de) | Verfahren zur Herstellung von 2-Mercapto-4-methyl-1,3-thiazol-5-yl-essigsäure und deren Ester. | |
| DE3854557D1 (de) | Stickstoffhaltige ester von carboxylgruppenhaltigen copolymerisaten. | |
| NZ194192A (en) | Long-acting injectable composition containing sulfadimethoxine or sulfamethazine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |